APA (7th ed.) Citation

Dong, Y., Kang, H., Peng, R., Liu, Z., Liao, F., Hu, S., . . . Song, K. (2024). A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis. Cell metabolism, 36(8), 1679-1695.e6. https://doi.org/10.1016/j.cmet.2024.03.005

Chicago Style (17th ed.) Citation

Dong, Yimin, et al. "A Clinical-stage Nrf2 Activator Suppresses Osteoclast Differentiation via the Iron-ornithine Axis." Cell Metabolism 36, no. 8 (2024): 1679-1695.e6. https://doi.org/10.1016/j.cmet.2024.03.005.

MLA (9th ed.) Citation

Dong, Yimin, et al. "A Clinical-stage Nrf2 Activator Suppresses Osteoclast Differentiation via the Iron-ornithine Axis." Cell Metabolism, vol. 36, no. 8, 2024, pp. 1679-1695.e6, https://doi.org/10.1016/j.cmet.2024.03.005.